Thermo Fisher Scientific Inc. has announced a collaboration that aims to advance personalized medicine and healthcare by providing expertise in mass spectrometry-based assays and establishing a new biomarker research center in Tokyo, Japan.
Participating in the venture are:
- Thermo Fisher’s Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Center, USA.
- Toshihide Nishimura, professor at the Tokyo Medical University Hospital, Japan.
- Gyorgy Marko-Varga, professor at the Tokyo Medical University Hospital, Japan.
- Lund University, Sweden.
Correlation of protein expression and quantitative regulation for diseases of key concern in Japan such as lung cancer, chronic obstructive pulmonary disease (COPD), and cardiovascular disease will be performed to discover biomarker candidates related to drug response. The research center will also house an archive with comprehensive tissue and blood sample collections, along with access to complementary clinical and demographic data. The archive will include samples from drug responder and non-responders, and material from clinical studies performed in Scandinavia and other European countries.
